Skip to main content

Table 2 Baseline comparison of relevant indexes before and after menopause

From: Epidemiological characteristics and risk factors of T2DM in Chinese premenopausal and postmenopausal women

 

Premenopausal

t/Z/χ 2

P

Postmenopausal

t/Z/χ 2

P

Non-diabetic

(n = 182)

Diabetic

(n = 25)

Non-diabetic

(n = 586)

Diabetic

(n = 2434)

Age (years)

46.65 ± 1.83

46.68 ± 1.38

0.083

0.934

60.05 ± 7.39

62.93 ± 7.75

8.158

< 0.001

BMI (kg/m2)

23.83 (21.975, 25.79)

24.91 (23.05, 27.78)

−1.896

0.058

24.27 (22.22,26.31)

25.39 (23.03, 27.99)

−7.181

< 0.001

WC (cm)

78 (73, 81)

81 (78, 90.5)

−2.553

0.011

81 (77, 84.25)

84 (80, 91)

−10.08

< 0.001

SBP (mmHg)

127.5 (120, 136.25)

130 (119.5, 162.5)

−1.324

0.185

134 (123, 149)

140 (130, 158.25)

−7.422

< 0.001

DBP (mmHg)

79 (70, 85)

85 (72.5, 92)

−1.616

0.106

81 (74, 90)

84 (76, 93.25)

−3.258

0.001

HbA1c (%)

5.4 (5.1, 5.7)

6.4 (5.6, 8.7)

−5.001

< 0.001

5.6 (5.3, 5.9)

6.8 (6.1, 7.8)

−29.113

< 0.001

FPG (mmol/L)

5.18 (4.88, 5.48)

5.43 (5.06, 8.52)

−2.949

0.003

5.35 (5.06, 5.74)

6.975 (5.67, 8.53)

−23.812

< 0.001

TC (mmol/L)

4.735 (4.21, 5.36)

4.51 (4.15, 5.6)

−0.429

0.668

5.24 (4.68, 5.8)

5.2 (4.63, 5.88)

−0.014

0.989

TG (mmol/L)

1.465 (1.12, 1.99)

1.55 (1.17, 2.17)

−0.815

0.415

1.73 (1.37, 2.28)

1.92 (1.5, 2.61)

−5.974

< 0.001

LDL-C (mmol/L)

2.445 (2.09, 2.76)

2.32 (1.915, 3.14)

−0.249

0.803

2.73 (2.31, 3.2)

2.75 (2.28, 3.2)

−0.010

0.992

UA (μmol/L)

236.8 (203.18,267.13)

227.8 (197.4, 269.7)

−0.274

0.784

251.9 (213.3294.5)

261.05 (218.5324.3)

−3.537

< 0.001

BUN (mg/dl)

4.405 (3.73, 5.22)

4.91 (3.75, 6.34)

−1.472

0.141

4.93 (4.21, 5.77)

5.055 (4.37, 6.01)

−2.808

0.005

ALT (U/L)

18 (14, 25)

19 (14, 25)

−0.483

0.629

20 (16, 25)

22 (18, 29)

−6.021

< 0.001

AST (U/L)

18 (15.75, 23)

16 (15.5, 21.5)

−0.662

0.508

20 (18, 24)

20 (17, 24)

−0.491

0.623

TP (g/L)

72.8 (70.6, 75)

75 (73.15, 77.55)

−3.084

0.002

74 (71.6, 76.3)

74.4 (72.2, 77)

−3.131

0.002

TBIL (μmol/L)

9.995 (7.84, 13.59)

9.15 (7.81, 13.56)

−0.564

0.572

10.845 (8.66,13.69)

10.99 (8.68, 14.03)

−0.620

0.535

eGFR (ml/min)

105.48 (97.45,108.81)

108.13 (98.56,111.67)

−1.718

0.086

92.93 (82.12,99.73)

92.66 (79.75, 99.41)

−1.068

0.286

Smoking n (%)

4 (2.2)

0 (0)

0.560

0.454

34 (1.4)

8 (1.4)

0.003

0.953

Drinking n (%)

4 (2.2)

2 (8)

2.630

0.105

32 (1.3)

2 (0.3)

4.020

0.045

History of Hypertension n (%)

17 (9.3)

8 (32)

10.630

0.001

751 (20.9)

293 (50)

76.536

< 0.001

History of CHD n (%)

4 (2.2)

2 (8)

2.630

0.110

115 (4.7)

54 (9.2)

18.030

< 0.001

History of sleep disorders n (%)

3 (1.6)

0 (0)

0.420

0.520

68 (2.8)

31 (5.3)

9.283

0.002

  1. Data are presented as the mean ± SD, number (as %), or median (range), as appropriate. Comparisons between the three groups were made using ANOVA or Fisher’s exact test, as appropriate International system of units (SI) conversion: BMI body mass index, CHD Coronary heart disease, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG triglycerides, UA uric acid, BUN blood urea nitrogen, e-GFR estimated glomerular filtration rate, FPG fasting plasma glucose, LDL-C low-density lipoprotein cholesterol, TBIL Total bilirubin, TP Total Protein
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X